Advoset is dedicated to providing training to the research community as a whole. Regulatory agencies have an awesome responsibility for their population's safety and their nation's approval of therapeutics. Advoset has created e-learning courses for all members of the research community: the pharmaceutical companies who are looking for more effective and efficient means of impact, the advocacy groups who support their research, and the academic community who continue to push the bounds of science. With our training, we encourage the community to work together to find new solutions for all patients. We provide a unique experience for all groups to stay better informed with the most up-to-date content in support of drug development and comparative effectiveness of interventions research.
Advoset will help you find solutions to fit your needs. We are here to help you navigate the research field, keeping you better informed of the latest information and technology. The federal government has just compiled the new clinical trial-related Title 21 CFR volumes for 2010 with all of the FDA rules for drugs, devices and biologics revised through April 1, 2010.